SeekingAlpha Medifast: Reorganization, GLP-1 Medication, And FCF Imply Undervaluation...\n more…
SeekingAlpha Medifast Business Continues To Shrink, Stock Still Risky...\n more…
Bizjournals.com - Retail news Many of Medifast's customers are already taking weight loss drugs. Now the Baltimore company is pivoting to serve them better.\n more…
Simply Wall St Medifast ( NYSE:MED ) Second Quarter 2024 Results Key Financial Results Revenue: US$168.6m (down 43% from 2Q 2023). Net...\n more…
SeekingAlpha Medifast, Inc. (MED) Q2 2024 Earnings Call Transcript...\n more…
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nMED stock results show that Medifast beat analyst estimates for earnings per share and beat on revenue for the second quarter of...\n more…